.jpg "Universal Health (NYSE: UHS)")
Barclays analyst Steven Valiquette maintained a Hold rating on Universal Health (NYSE: UHS) on October 26 and set a price target of $130. The company’s shares opened today at $115.95.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 6.0% and a 49.4% success rate. Valiquette covers the Services sector, focusing on stocks such as Patterson Companies Inc, WellCare Health Plans, and Molina Healthcare.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Universal Health with a $135.50 average price target, representing a 16.9% upside. In a report issued on October 17, Piper Jaffray also maintained a Hold rating on the stock with a $118 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $132.64 and a one-year low of $95.26. Currently, Universal Health has an average volume of 676.1K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Universal Health Services, Inc. operates as a healthcare management company, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. It operates through the Acute Care Hospital Services, Behavioral Health Care Services, and Other.
